Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in Spain

Background: Has been described the loss of smell and taste as onset symptoms in SARS-CoV-2. The objective of this study was to investigate the prevalence in Spain. Methods: Prospective study of COVID-19 confirmed patients through RT-PCR in Spain. Patients completed olfactory and gustatory questionna...

Descripción completa

Detalles Bibliográficos
Autores: Ninchritz-Becerra E, Soriano-Reixach MM, Mayo-Yánez M, Calvo-Henríquez C, Martínez-Ruiz de Apodaca P, Saga-Gutiérrez C, Parente-Arias P, Villareal IM, Viera-Artiles J, Poletti-Serafini D, Alobid I, Ayad T, Saussez S, Lechien JR, Chiesa-Estomba CM
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:España
Institución:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Repositorio:r-FISABIO. Repositorio Institucional de Producción Científica
OAI Identifier:oai:fisabio.fundanetsuite.com:p8311
Acceso en línea:https://fisabio.portalinvestigacion.com/publicaciones/8311
Access Level:acceso abierto
Palabra clave:COVID-19
SARS-CoV-2
Anosmia
Ageusia
id ES_e2ddafef20bf4570ac08979e51fa1561
oai_identifier_str oai:fisabio.fundanetsuite.com:p8311
network_acronym_str ES
network_name_str España
repository_id_str
spelling Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in SpainNinchritz-Becerra ESoriano-Reixach MMMayo-Yánez MCalvo-Henríquez CMartínez-Ruiz de Apodaca PSaga-Gutiérrez CParente-Arias PVillareal IMViera-Artiles JPoletti-Serafini DAlobid IAyad TSaussez SLechien JRChiesa-Estomba CMCOVID-19SARS-CoV-2AnosmiaAgeusiaBackground: Has been described the loss of smell and taste as onset symptoms in SARS-CoV-2. The objective of this study was to investigate the prevalence in Spain. Methods: Prospective study of COVID-19 confirmed patients through RT-PCR in Spain. Patients completed olfactory and gustatory questionnaires. Results: A total of 1043 patients with mild COVID-19 disease. The mean age was 39 +/- 12 years. 826 patients (79.2%) described smell disorder, 662 (63.4%) as a total loss and 164 (15.7%) partial. 718 patients (68.8%) noticed some grade of taste dysfunction. There was a significant association between both disorders (p< .001). The olfactory dysfunction was the first symptom in 17.1%. The sQOD-NS scores were significantly lower in patients with a total loss compare to normosmic or hyposmic individuals (p = .001). Female were significantly more affected by olfactory and gustatory dysfunctions (p< .001). The early olfactory recover in 462 clinically cured patients was 315 (68.2%), during the first 4 weeks. Conclusion: The sudden onset smell and/or taste dysfunction should be considered highly suspicious for COVID-19 infection. (C) 2020 Elsevier Espaila, S.L.U. All rights reserved.ELSEVIER ESPANA SLU2021info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://fisabio.portalinvestigacion.com/publicaciones/8311MEDICINA CLINICAISSN: 00257753ISSNe: 15788989reponame:r-FISABIO. Repositorio Institucional de Producción Científicainstname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)Inglésinfo:eu-repo/semantics/openAccessoai:fisabio.fundanetsuite.com:p83112026-06-11T12:45:17Z
dc.title.none.fl_str_mv Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in Spain
title Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in Spain
spellingShingle Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in Spain
Ninchritz-Becerra E
COVID-19
SARS-CoV-2
Anosmia
Ageusia
title_short Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in Spain
title_full Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in Spain
title_fullStr Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in Spain
title_full_unstemmed Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in Spain
title_sort Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in Spain
dc.creator.none.fl_str_mv Ninchritz-Becerra E
Soriano-Reixach MM
Mayo-Yánez M
Calvo-Henríquez C
Martínez-Ruiz de Apodaca P
Saga-Gutiérrez C
Parente-Arias P
Villareal IM
Viera-Artiles J
Poletti-Serafini D
Alobid I
Ayad T
Saussez S
Lechien JR
Chiesa-Estomba CM
author Ninchritz-Becerra E
author_facet Ninchritz-Becerra E
Soriano-Reixach MM
Mayo-Yánez M
Calvo-Henríquez C
Martínez-Ruiz de Apodaca P
Saga-Gutiérrez C
Parente-Arias P
Villareal IM
Viera-Artiles J
Poletti-Serafini D
Alobid I
Ayad T
Saussez S
Lechien JR
Chiesa-Estomba CM
author_role author
author2 Soriano-Reixach MM
Mayo-Yánez M
Calvo-Henríquez C
Martínez-Ruiz de Apodaca P
Saga-Gutiérrez C
Parente-Arias P
Villareal IM
Viera-Artiles J
Poletti-Serafini D
Alobid I
Ayad T
Saussez S
Lechien JR
Chiesa-Estomba CM
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv COVID-19
SARS-CoV-2
Anosmia
Ageusia
topic COVID-19
SARS-CoV-2
Anosmia
Ageusia
description Background: Has been described the loss of smell and taste as onset symptoms in SARS-CoV-2. The objective of this study was to investigate the prevalence in Spain. Methods: Prospective study of COVID-19 confirmed patients through RT-PCR in Spain. Patients completed olfactory and gustatory questionnaires. Results: A total of 1043 patients with mild COVID-19 disease. The mean age was 39 +/- 12 years. 826 patients (79.2%) described smell disorder, 662 (63.4%) as a total loss and 164 (15.7%) partial. 718 patients (68.8%) noticed some grade of taste dysfunction. There was a significant association between both disorders (p< .001). The olfactory dysfunction was the first symptom in 17.1%. The sQOD-NS scores were significantly lower in patients with a total loss compare to normosmic or hyposmic individuals (p = .001). Female were significantly more affected by olfactory and gustatory dysfunctions (p< .001). The early olfactory recover in 462 clinically cured patients was 315 (68.2%), during the first 4 weeks. Conclusion: The sudden onset smell and/or taste dysfunction should be considered highly suspicious for COVID-19 infection. (C) 2020 Elsevier Espaila, S.L.U. All rights reserved.
publishDate 2021
dc.date.none.fl_str_mv 2021
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://fisabio.portalinvestigacion.com/publicaciones/8311
url https://fisabio.portalinvestigacion.com/publicaciones/8311
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv ELSEVIER ESPANA SLU
publisher.none.fl_str_mv ELSEVIER ESPANA SLU
dc.source.none.fl_str_mv MEDICINA CLINICA
ISSN: 00257753
ISSNe: 15788989
reponame:r-FISABIO. Repositorio Institucional de Producción Científica
instname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
instname_str Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
reponame_str r-FISABIO. Repositorio Institucional de Producción Científica
collection r-FISABIO. Repositorio Institucional de Producción Científica
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869422449467064320
score 15,812429

Similares en LA Referencia